07.05.2012 | Symbiotics Holds a Investor Knowledge Sharing Day in Geneva

Symbiotics Investor Knowledge Sharing Day 2012, over 180 participants gather to discuss new products in emerging sustainable investments

Over 180 people from Switzerland and beyond, including staff, directors and shareholders but primarily clients and investors, attended Symbiotics' Investor Knowledge Sharing Day 2012 on May 2nd in Geneva, which covered much of the company's new activities in the wider space of emerging sustainable investments.  

The main objective of the event was to gather a large spectrum of traditional investors and share with them on the newest developments in the industry, presenting and getting feedback on Symbiotics' approach of the market in 2012. The event included external speakers, such as impact investing managers at Credit Suisse, Lombard Odier and UBS or large pension fund managers such as Nest and Fundo in Switzerland. In particular, the company kicked off the day by presenting its new fund of fund in partnership with Gonet & Cie - Banquier Privés: Symbitoics Sicav - Emerging Sustainable Funds. Symbiotics also shared its field experience during a lunch presentation given by its regional managers, and headed small workshop discussions on key topics, including forex strategies, pension funds strategies, listed equities and listed bonds in the area of impact investing.

Fabio Sofia, Head of Investor Relations remarks: "We were really pleased to see so many people coming from the traditional banking industry interested in microfinance and impact investing. We were able to give a larger view point of this growing asset class with the addition of larger banks joining us in the panels and discussions to stress the importance of moving into these markets and creating opportunity in sustainable development for investors. The excellent turnout and diversity allowed for some very interesting exchanges." 

For more information:

Claire Dorey

Communication Officer

+41 22 338 1540

claire.dorey@symbioticsgroup.com

 

Legal Disclaimer: The collective investment schemes (the “Investment Products”) referred to on the following pages have not been approved for public distribution in or from Switzerland by the Swiss Financial Market Supervisory Authority (FINMA) pursuant to the Swiss Collective Investment Schemes Act of 23 June 2006 (the "CISA") and its implementing regulations. Accordingly, units of such Investment Products and information, documents or material pertaining to these Investment Products on the following pages may only be distributed in or from Switzerland to qualified investors (as such term is defined in the CISA and its implementing regulations). The information, documents and material pertaining to these Investment Products on the following pages are strictly confidential and do not constitute an offer to any other person or entity than Swiss qualified investors and may only be used by those qualified investors who have accessed them. They may not be copied, used by, distributed or made available to any other person.

Similarly the information on the following pages is only intended to be viewed by persons who fall outside the scope of any law that seeks to regulate financial promotions in the country of your residence or in the country in which the content of this website is being viewed.

If you are uncertain about your position under the laws of the country in which the content of this website is being viewed then you should seek clarification by obtaining legal advice from a lawyer practicing in the country of your residence or in the country in which the content of this website is being viewed before accessing this website.

The information, documents and material contained in the following pages are not warranted to be accurate, complete, or timely. More specifically, Symbiotics SA may not be held responsible for and does not take any position with respect to the accuracy and completeness of information in the following pages.

Agree    Disagree